New, patent pending superior scientific resolution assist system (CDSS) precisely detects fetal coronary heart charge accelerations and decelerations throughout distant non-stress exams (NSTs), additional demonstrating feasibility of telehealth options for high-risk pregnancies
TEL AVIV, Israel, Feb. 3, 2022 /PRNewswire/ — Nuvo Group, a pacesetter in fashionable maternal-fetal well being, immediately offered new scientific knowledge for INVUTM, the one FDA-cleared, prescription-initiated, distant being pregnant monitoring and administration platform, on the Society for Maternal Fetal Medication (SMFM)’s 42nd Annual Being pregnant Assembly. The info, offered in a scientific poster, “Expertise with home-based, distant non-stress exams, together with computerized resolution assist for interpretation of reactivity,” demonstrates the feasibility of telehealth options for high-risk pregnancies by means of distant fetal non-stress exams (NSTs) and the novel machine studying scientific resolution assist system (CDSS) to detect fetal coronary heart charge accelerations. This examine comes on the heels of a latest publication within the American Journal of Obstetrics and Gynecology (AJOG) titled, “Novel uterine contraction monitoring to allow distant, self-administered nonstress testing,” which firmly establishes INVU’s distinctive capabilities as an revolutionary telehealth resolution.
The examine, carried out by researchers on the Perelman Faculty of Medication on the College of Pennsylvania and Nuvo Group, and sponsored by Nuvo Group, was carried out with girls who had been better than 32 gestational weeks in a high-risk singleton being pregnant utilizing the INVU machine at dwelling. The NSTs had been reviewed by clinicians by way of the INVU web-based supplier dashboard. Of the 30 at-home classes, clinicians deemed 27 such classes as interpretable, validating the flexibility of the INVU system to remotely seize medical grade NSTs. Classes had been then analyzed by the CDSS for reactivity in comparison with the clinicians’ assessments. The CDSS appropriately categorized 92.6 p.c of the interpretable NSTs in contrast with clinicians. As well as, the CDSS software decided the NST to be reactive a median of 14 minutes earlier within the session, probably lowering the size of NST classes and bettering clinician workflow.
NSTs for high-risk pregnancies are frequent and historically carried out with a affected person and supplier in a scientific setting. As soon as a being pregnant has been deemed excessive danger, which frequently occurs after 26-28 weeks of gestation, NSTs could also be beneficial a few times per week—and sometimes every day. With INVU, pregnant sufferers are given the chance to conduct correct testing beneath the supervision of their physician from the consolation of dwelling. INVU safely and precisely shifts the purpose of care and frees up time for each the physician and the affected person.
“We’re very happy with the examine outcomes showcasing our potential to efficiently conduct non-stress exams remotely in addition to the subsequent layer in our technological stack: the flexibility to precisely assist the scientific workflow by means of an automatic scientific resolution assist system,” says Amit Reches, chief expertise officer, Nuvo Group. “Taken collectively, these capabilities have the potential to considerably enhance being pregnant take care of each the scientific care workforce and expectant moms.”
“The outcomes of this analysis are very promising for the way forward for at-home being pregnant monitoring for high-risk pregnancies that sometimes require frequent physician visits,” stated Nadav Schwartz, MD, an affiliate professor of Obstetrics and Gynecology on the Perelman Faculty of Medication on the College of Pennsylvania and a medical advisor to Nuvo Group. “At-home NST testing can develop choices and reduce the burden for pregnant girls and their healthcare suppliers.”
About Nuvo Group
Based mostly in Tel Aviv, Israel, Nuvo Group Ltd. (“Nuvo”) is dedicated to reinventing being pregnant take care of the twenty first century by means of new expertise, instruments, and practices for suppliers and expectant moms, together with the INVU by Nuvo™ platform, an FDA-cleared, prescription initiated distant being pregnant monitoring and administration system. The INVU™ sensor band allows the supply of distant non-stress exams and maternal & fetal coronary heart charge monitoring immediately whereas pioneering new data-driven personalised pathways that Nuvo believes will assist enhance well being outcomes for all girls sooner or later. The expertise and patent property that underpin the INVU platform have been awarded various trade recognitions, together with Quick Firm’s Subsequent Massive Issues in Tech (2021), CB Insights’ Digital Well being 150 (2020), and MedTech Innovator’s Prime 50 MedTech Startups (2021), in addition to a number of grants from a number of the world’s main educational medical facilities and scientific our bodies. Nuvo is led by a various workforce of skilled enterprise and medical professionals, devoted knowledge engineers, software program designers and proud mother and father who embrace a collective mission to offer each life a greater starting.
For extra info and full indications, contraindications, warnings and precautions together with directions to be used, go to: www.nuvocares.com.
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/nuvo-group-presents-new-data-supporting-expanded-capability-of-invu-platform-for-remote-high-risk-pregnancy-monitoring-at-society-of-maternal-fetal-medicines-42nd-annual-pregnancy-meeting-301474406.html
SOURCE Nuvo Group